Dr. Mark Sulkowski, MD

Dr. Sulkowski practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Sulkowski's NPI, 1790715423, was assigned on July 5, 2006. Dr. Sulkowski graduated from Lewis Katz School of Medicine at Temple University in 1992. Dr. Sulkowski holds Maryland license D50380.

Dr. Sulkowski's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Sulkowski's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Sulkowski is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Sulkowski to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sulkowski practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Sulkowski's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Sulkowski is licensed in Maryland.

CMS data shows 105 Medicare services from Dr. Sulkowski across 4 procedure codes in 2024, for 63 Medicare patients. Medicare paid $5,241 for them.

CMS counts 63 Medicare patients who saw Dr. Sulkowski in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sulkowski's median patient age at 69, with 44% women.

In 2024, Dr. Sulkowski wrote 152 Medicare Part D claims for 12 patients. 70% of them were for generic drugs. CMS names the drug for 80 of them, across 5 drugs with 11 or more claims each, at $126,831 in total drug cost. In 2023, CMS named 44 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Sulkowski for performance year 2024, reported as part of a group. CMS lists Dr. Sulkowski as offering telehealth.

Dmand AI links 151 papers to Dr. Sulkowski, published from 2016 to 2025. 2016 was the busiest year, with 23. The most frequent topics are Antiviral Agents, Hepatitis C and Hepacivirus. Dr. Sulkowski has published most often in Clin Infect Dis. Dr. Sulkowski's most frequent co-authors are Richard K. Sterling, MD, David L. Wyles, MD and Diana Marina Brainard, MD.

CMS Open Payments shows 418 general payments to Dr. Sulkowski from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. Gilead Sciences, Inc. paid the most, $239,281. It also lists 20 research payments totaling $25,759 from 2016 to 2020.

Dr. Sulkowski graduated from Lewis Katz School of Medicine at Temple University in 1992.